NASDAQ:NVCR - Novocure News Headlines

$55.08
-1.98 (-3.47 %)
(As of 06/17/2019 04:00 PM ET)
Today's Range
$54.94
Now: $55.08
$57.75
50-Day Range
$43.28
MA: $51.37
$57.99
52-Week Range
$26.02
Now: $55.08
$58.50
Volume370,941 shs
Average Volume629,219 shs
Market Capitalization$5.27 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.42

Headlines

Novocure (NASDAQ NVCR) News Headlines

Source:
DateHeadline
The Daily Biotech Pulse: Hematology And Rheumatology Conference Presentations Take The Spotlight, Eton In-Licenses Epilepsy Drug NDA - BenzingaThe Daily Biotech Pulse: Hematology And Rheumatology Conference Presentations Take The Spotlight, Eton In-Licenses Epilepsy Drug NDA - Benzinga
www.benzinga.com - June 15 at 6:25 AM
Hedge Funds Have Never Been This Bullish On NovoCure Limited (NVCR)Hedge Funds Have Never Been This Bullish On NovoCure Limited (NVCR)
finance.yahoo.com - June 15 at 6:25 AM
EndBrainCancer Initiative Announced Campaign for New Brain Cancer Clinical Trials in the Greater Puget Sound Area at its Education, Awareness & Action Dinner - Yahoo FinanceEndBrainCancer Initiative Announced Campaign for New Brain Cancer Clinical Trials in the Greater Puget Sound Area at its Education, Awareness & Action Dinner - Yahoo Finance
finance.yahoo.com - June 13 at 7:47 PM
Why NovoCures Regulatory News Is a Huge Win for Investors - The Motley FoolWhy NovoCure's Regulatory News Is a Huge Win for Investors - The Motley Fool
www.fool.com - June 13 at 7:47 PM
Asaf Danziger Sells 30,436 Shares of Novocure Ltd (NASDAQ:NVCR) StockAsaf Danziger Sells 30,436 Shares of Novocure Ltd (NASDAQ:NVCR) Stock
www.americanbankingnews.com - June 13 at 5:20 PM
Pritesh Shah Sells 1,130 Shares of Novocure Ltd (NASDAQ:NVCR) StockPritesh Shah Sells 1,130 Shares of Novocure Ltd (NASDAQ:NVCR) Stock
www.americanbankingnews.com - June 12 at 6:01 PM
Is NovoCure Limiteds (NASDAQ:NVCR) CEO Overpaid Relative To Its Peers? - Yahoo FinanceIs NovoCure Limited's (NASDAQ:NVCR) CEO Overpaid Relative To Its Peers? - Yahoo Finance
finance.yahoo.com - June 12 at 5:58 PM
Is NovoCure Limited's (NASDAQ:NVCR) CEO Overpaid Relative To Its Peers?Is NovoCure Limited's (NASDAQ:NVCR) CEO Overpaid Relative To Its Peers?
finance.yahoo.com - June 12 at 5:58 PM
Why NovoCure's Regulatory News Is a Huge Win for InvestorsWhy NovoCure's Regulatory News Is a Huge Win for Investors
finance.yahoo.com - June 12 at 5:58 PM
Gabriel Leung Sells 5,000 Shares of Novocure Ltd (NASDAQ:NVCR) StockGabriel Leung Sells 5,000 Shares of Novocure Ltd (NASDAQ:NVCR) Stock
www.americanbankingnews.com - June 12 at 5:42 PM
Zacks: Brokerages Anticipate Novocure Ltd (NASDAQ:NVCR) Will Announce Quarterly Sales of $83.02 MillionZacks: Brokerages Anticipate Novocure Ltd (NASDAQ:NVCR) Will Announce Quarterly Sales of $83.02 Million
www.americanbankingnews.com - June 12 at 1:46 AM
Novocure Ltd (NASDAQ:NVCR) Expected to Announce Earnings of -$0.06 Per ShareNovocure Ltd (NASDAQ:NVCR) Expected to Announce Earnings of -$0.06 Per Share
www.americanbankingnews.com - June 10 at 6:16 PM
Novocure Ltd (NASDAQ:NVCR) COO Michael J. Ambrogi Sells 5,999 SharesNovocure Ltd (NASDAQ:NVCR) COO Michael J. Ambrogi Sells 5,999 Shares
www.americanbankingnews.com - June 10 at 5:41 PM
You Need This IPO On Your Radar - Yahoo FinanceYou Need This IPO On Your Radar - Yahoo Finance
finance.yahoo.com - June 7 at 4:02 PM
Why NovoCure Stock Jumped 20.5% in May - Motley FoolWhy NovoCure Stock Jumped 20.5% in May - Motley Fool
www.fool.com - June 6 at 7:20 PM
Why NovoCure Stock Jumped 20.5% in May - Yahoo FinanceWhy NovoCure Stock Jumped 20.5% in May - Yahoo Finance
finance.yahoo.com - June 6 at 8:12 AM
Why NovoCure Stock Jumped 20.5% in MayWhy NovoCure Stock Jumped 20.5% in May
finance.yahoo.com - June 6 at 8:11 AM
Novocure Ltd (NVCR) COO Sells $1,841,700.00 in StockNovocure Ltd (NVCR) COO Sells $1,841,700.00 in Stock
www.americanbankingnews.com - June 5 at 5:13 PM
3 Fast-Growing Healthcare Stocks to Buy If the Market Crashes - Yahoo Finance3 Fast-Growing Healthcare Stocks to Buy If the Market Crashes - Yahoo Finance
finance.yahoo.com - June 3 at 8:09 AM
3 Fast-Growing Healthcare Stocks to Buy If the Market Crashes3 Fast-Growing Healthcare Stocks to Buy If the Market Crashes
finance.yahoo.com - June 3 at 8:09 AM
Novocure Ltd (NVCR) Insider Sells $100,890.00 in StockNovocure Ltd (NVCR) Insider Sells $100,890.00 in Stock
www.americanbankingnews.com - May 31 at 5:40 PM
Insider Selling: Novocure Ltd (NVCR) Director Sells 95,100 Shares of StockInsider Selling: Novocure Ltd (NVCR) Director Sells 95,100 Shares of Stock
www.americanbankingnews.com - May 31 at 5:25 PM
Novocure Ltd (NVCR) Receives Average Rating of "Buy" from AnalystsNovocure Ltd (NVCR) Receives Average Rating of "Buy" from Analysts
www.americanbankingnews.com - May 27 at 6:37 AM
Novocure (NVCR) Receives "Buy" Rating from JPMorgan Chase & Co.Novocure (NVCR) Receives "Buy" Rating from JPMorgan Chase & Co.
www.americanbankingnews.com - May 26 at 10:43 AM
FDA Approves the NovoTTF-100LTM System in Combination with Chemotherapy for the Treatment of Malignant Pleural Mesothelioma - Yahoo FinanceFDA Approves the NovoTTF-100LTM System in Combination with Chemotherapy for the Treatment of Malignant Pleural Mesothelioma - Yahoo Finance
finance.yahoo.com - May 25 at 5:42 PM
Wedbush Reaffirms "Outperform" Rating for Novocure (NVCR)Wedbush Reaffirms "Outperform" Rating for Novocure (NVCR)
www.americanbankingnews.com - May 24 at 9:51 AM
Novocure (NVCR) Announces FDA Approves NovoTTF-100LTM System in Combination with Chemotherapy for Treatment of MPM - StreetInsider.comNovocure (NVCR) Announces FDA Approves NovoTTF-100LTM System in Combination with Chemotherapy for Treatment of MPM - StreetInsider.com
www.streetinsider.com - May 24 at 8:16 AM
Novocure to Participate in the Jefferies 2019 Global Healthcare ConferenceNovocure to Participate in the Jefferies 2019 Global Healthcare Conference
finance.yahoo.com - May 24 at 8:15 AM
FDA Approves the NovoTTF-100LTM System in Combination with Chemotherapy for the Treatment of Malignant Pleural Mesothelioma - Business WireFDA Approves the NovoTTF-100LTM System in Combination with Chemotherapy for the Treatment of Malignant Pleural Mesothelioma - Business Wire
www.businesswire.com - May 23 at 7:32 PM
FDA Approves the NovoTTF-100LTM System in Combination with Chemotherapy for the Treatment of Malignant Pleural MesotheliomaFDA Approves the NovoTTF-100LTM System in Combination with Chemotherapy for the Treatment of Malignant Pleural Mesothelioma
finance.yahoo.com - May 23 at 7:32 PM
Head to Head Analysis: PAVmed (PAVM) & Novocure (NVCR)Head to Head Analysis: PAVmed (PAVM) & Novocure (NVCR)
www.americanbankingnews.com - May 23 at 6:25 AM
Insulet and Novocure Are Going Gangbusters - Motley FoolInsulet and Novocure Are Going Gangbusters - Motley Fool
www.fool.com - May 13 at 8:08 AM
Novocure (NVCR) Says Medicare Issued Proposed Local Coverage Determination that Provides Coverage of Optune for Newly Diagnosed Glioblastoma - StreetInsider.comNovocure (NVCR) Says Medicare Issued Proposed Local Coverage Determination that Provides Coverage of Optune for Newly Diagnosed Glioblastoma - StreetInsider.com
www.streetinsider.com - May 10 at 7:03 PM
Novocure up 2% premarket on proposed Medicare coverage of Optune - Seeking AlphaNovocure up 2% premarket on proposed Medicare coverage of Optune - Seeking Alpha
seekingalpha.com - May 10 at 7:03 PM
Medicare Issues Proposed Local Coverage Determination that Provides Coverage of Optune® for Newly Diagnosed GlioblastomaMedicare Issues Proposed Local Coverage Determination that Provides Coverage of Optune® for Newly Diagnosed Glioblastoma
finance.yahoo.com - May 10 at 8:14 AM
5 Key Takeaways From NovoCures Big First Quarter - Motley Fool5 Key Takeaways From NovoCure's Big First Quarter - Motley Fool
www.fool.com - May 8 at 8:13 AM
5 Key Takeaways From NovoCure's Big First-Quarter5 Key Takeaways From NovoCure's Big First-Quarter
finance.yahoo.com - May 7 at 7:08 PM
Novocure Reports First Quarter 2019 Financial Results and Provides Company Update - Business WireNovocure Reports First Quarter 2019 Financial Results and Provides Company Update - Business Wire
www.businesswire.com - May 3 at 7:24 PM
Edited Transcript of NVCR earnings conference call or presentation 2-May-19 12:00pm GMTEdited Transcript of NVCR earnings conference call or presentation 2-May-19 12:00pm GMT
finance.yahoo.com - May 3 at 7:24 PM
NovoCure Limited (NVCR) Q1 2019 Earnings Call Transcript - Yahoo FinanceNovoCure Limited (NVCR) Q1 2019 Earnings Call Transcript - Yahoo Finance
finance.yahoo.com - May 3 at 8:20 AM
NovoCure (NVCR) Reports Q1 Loss, Misses Revenue Estimates - Yahoo FinanceNovoCure (NVCR) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
finance.yahoo.com - May 2 at 8:06 PM
Novocure Limited (NVCR) CEO Asaf Danziger on Q1 2019 Results - Earnings Call Transcript - Seeking AlphaNovocure Limited (NVCR) CEO Asaf Danziger on Q1 2019 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - May 2 at 8:06 PM
Novocure (NVCR) Tops Q1 EPS by 1c, Revenues Beat - StreetInsider.comNovocure (NVCR) Tops Q1 EPS by 1c, Revenues Beat - StreetInsider.com
www.streetinsider.com - May 2 at 8:15 AM
NovoCure Limited 2019 Q1 - Results - Earnings Call Slides - Seeking AlphaNovoCure Limited 2019 Q1 - Results - Earnings Call Slides - Seeking Alpha
seekingalpha.com - May 2 at 8:15 AM
NovoCure (NVCR) Reports Q1 Loss, Misses Revenue EstimatesNovoCure (NVCR) Reports Q1 Loss, Misses Revenue Estimates
finance.yahoo.com - May 2 at 8:15 AM
NovoCure Q1 Earnings Preview - Seeking AlphaNovoCure Q1 Earnings Preview - Seeking Alpha
seekingalpha.com - May 1 at 7:35 PM
The NovoCure (NASDAQ:NVCR) Share Price Is Up 275% And Shareholders Are Boasting About It - Yahoo FinanceThe NovoCure (NASDAQ:NVCR) Share Price Is Up 275% And Shareholders Are Boasting About It - Yahoo Finance
finance.yahoo.com - May 1 at 8:10 AM
The NovoCure (NASDAQ:NVCR) Share Price Is Up 275% And Shareholders Are Boasting About ItThe NovoCure (NASDAQ:NVCR) Share Price Is Up 275% And Shareholders Are Boasting About It
finance.yahoo.com - April 30 at 7:00 PM
Cramers lightning round: A medical device company should acquire this - CNBCCramer's lightning round: A medical device company should acquire this - CNBC
www.cnbc.com - April 30 at 8:08 AM
Novocure Announces the International Journal of Radiation Oncology, Biology, Physics Publishes Data Demonstrating Higher Doses of Tumor Treating Fields Improved Survival of Newly Diagnosed Glioblastoma Patients - Yahoo FinanceNovocure Announces the International Journal of Radiation Oncology, Biology, Physics Publishes Data Demonstrating Higher Doses of Tumor Treating Fields Improved Survival of Newly Diagnosed Glioblastoma Patients - Yahoo Finance
finance.yahoo.com - April 30 at 8:08 AM
This page was last updated on 6/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel